COMPARISION OF THE APOPTOTIC EFFECTS ON LYMPHOBLASTS AND ON INCREASE OF MYELOID LINEAGE CELLS OF A SHORT-TIME, HIGH-DOSE METHYLPREDNISOLONE AND THE CONVENTIONAL-DOSE PREDNISOLONE TREATMENTS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

REFERENCES

• Pui C-H, Schrappe M, Riberio R C, Niemeyer C M. Childhood and adolescent lymphoid and myeloid leukemia. American Society of Hematology Education Program Book 2004; 118–145
   Google Scholar
• Schimmer A D, Hedley D W. Receptor-and mitochondrial-mediated apoptosis in acute leukemia: a translational view. Blood 2001; 98: 3541–3553, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Helmberg A, Auphan N, Caelles C. Glucocorticoid-induced apoptosis of human leukemic cells is caused by the repressive function of the glucocorticoid receptor. EMBO J 1995; 14: 452–460, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Harmon J M., Norman M R., Fowlkes B J. Dexamethasone induces irreversible G1 arrest and death of a human lymphoid cell line. J Cell Physiol 1979; 98: 267–278, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Shanbrom E, Miller S. Critical evaluation of massive steroid therapy of acute leukemia. N Engl J Med 1962; 266: 1354–1358, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Hicsonmez G, Ozsoylu S, Onat N, Zamani V P. High-dose methylprednisolone in resistant and relapsed children with acute lymphoblastic leukemia. Med Pediatr Oncol 1994; 22: 68–69, [CSA]
   PubMedGoogle Scholar
• Ryalls M R, Pinkerton C R, Meller S T. High-dose methylprednisolone sodium succinate as a single agent in relapsed childhood acute lymphoblastic leukemia. Med Pediatr Oncol 1992; 20: 119–123, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Yetgin S, Tuncer M A, Cetin M. Benefit of high-dose methylprednisolone in comparison of conventional dose prednisolone during remission induction therapy in childhood acute lymphoblastic leukemia for long-period follow-up. Leukemia 2003; 17: 328–333, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Saikumar P, Dong Z, Mikhailov V, Denton M, Weinberg J M, Venkatachalam M A. Apoptosis: definition, mechanisms, and relevance to disease. Am J Med 1999; 107: 489–506, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Erduran E, Tekelioglu Y, Gedik Y, Yildiran A. Apoptotic effects of heparin on lymphoblast, neutrophils, and mononuclear cells: results of a preliminary in vitro study. Am J Hematol 1999; 61: 90–93, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Erduran E, Tekelioglu Y, Gedik Y, Bektas I, Hacisalihoglu S. In vitro determination of the apoptotic effect of heparın on lymphoblasts using DNA analysis and measurements of Fas and Bcl-2 proteins by flow cytometry. Pediatr Hematol Oncol 2004; 21: 383–391, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Yıldıran A, Erduran E, Tekelioğlu Y, Dilber E, Gedik Y. Proliferation of myeloid lineage cells and apoptosis of lymphoblastic leukemic cells induced by short-course high-dose methylprednisolone in patients with acute lymphoblastic leukemia. Turk J Pediatr 2002; 44: 116–121, [CSA]
   PubMedGoogle Scholar
• Tuncer A M, Hicsonmez G, Erturk G, Gumruk F, Albayrak D, Oguz H. The effect of high-dose methylprednisolone treatment on GM-CSF level in children with acute leukemia: a pilot study. Leuk Res 1992; 16: 615–619, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Yetgin S, Gurgey A, Tuncer A M. A comparison of the effect of high-dose methylprednisolone with conventional-dose prednisolone in acute lymphoblastic leukemia children with randomization. Leuk Res 1998; 22: 485–493, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Tuncer A M, Hicsonmez G, Gumruk F. Serum TNF-alfa, gamma-INF, G-CSF and GM-CSF levels in neutropenic children with acute leukemia treated with short-course, high-dose methylprednisolone. Leuk Res 1996; 20: 265–269, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• De Bosscher K., Van den Berghe W., Haegeman G. Mechanisms of anti-inflammatory action and of immunosuppression by glucocorticoids: negative interference of activated glucocorticoid receptor with transcription factors. J Neuroimmunol 2000; 109: 16–22, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Moalli P A, Pillay S, Weiner D. A mechanism of resistance to glucocorticoids in multiple myeloma: transient expression of a truncated glucocorticoid receptor mRNA. Blood 1992; 79: 213–222, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• King K, Cidlowski J. Cell cycle regulation and apoptosis. Annu Rev Physiol 1998; 60: 601–617, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Chandra J, Niemer I, Gilbreath J, Kliche K O. Protease activation is required for glucocorticoid-induced apoptosis in chronic lymphocytic leukemic lymphocytes. Blood 1997; 90: 3673–3681, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kofler R. The molecular basis of glucocorticoid-induced apoptosis of lymphoblastic leukemia cells. Histochem Cell Biol 2000; 114: 1–7, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Miyashita T, Krajewski S, Krajewska M. Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 1994; 9: 1799–1805, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Jonat C, Rahmsdorf H. J., Park K K, Cato A C. Anti-tumor promotion and anti-inflammation: down-modulation of AP-1 (Fos Jun) activity by glucocorticoid hormone. Cell 1990; 62: 1189–1204, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• De Bosscher K, Vanden Berghe W, Vermeulen L. Glucocorticoids repress NF-κB-driven genes by disturbing the interaction of p65 with the basal transcription machinery, irrespective of coactivator levels in the cell. Proc Natl Acad Sci USA 2000; 97: 3919–3924, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Distelhorst C W., Dubyak G. Role of calcium in glucocorticosteroid-induced apoptosis of thymocytes and lymphoma cells: resurrection of old theories by new findings. Blood 1998; 91: 731–734, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Tunc B, Oner A F, Hicsonmez G. The effect of short-course high-dose methylprednisolone on peripheral blood CD34+ progenitor cells of children with acute leukemia during remission induction therapy. Turk J Pediatr 2002; 44: 1–4, [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Csoka M, Bocsi J, Falus A. Glucocorticoid-induced apoptosis and treatment sensitivity in acute lymphoblastic leukemia of children. Pediatr Hematol Oncol 1997; 14: 433–442, [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Uckan D, Yetgin S, Çetın M, Ozyurek E. The effects of high dose methylprednisolone on apoptosis in children with acute lymphoblastic leukemia. Clin Lab Haematol 2003; 25: 35–40, [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Hicsonmez G, Onat N, Albayrak D, Yetgin S, Ozsoylu S. Acceleration of leukocyte recovery by administration of short-course high-dose methylprednisolone in children with acute lymphoblastik leukemia. Pedlater Hematol Oncol 1991; 8: 193–197, [CSA]
   PubMed Web of Science ®Google Scholar
• Hicsonmez G. The effect of steroid on myeloid leukemic cells:the potential of short-course high-dose methylprednisolone treatment in inducing differentiation, apoptosis and in stimulating myelopoiesis. Leukemia Res 2006; 30: 60–68, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar